Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 144

1.

Eye of the beholder? Observation versus self-report in the measurement of disrespect and abuse during facility-based childbirth.

Freedman LP, Kujawski SA, Mbuyita S, Kuwawenaruwa A, Kruk ME, Ramsey K, Mbaruku G.

Reprod Health Matters. 2018;26(53):107-122. doi: 10.1080/09688080.2018.1502024. Epub 2018 Sep 10.

2.

Community health workers and accountability: reflections from an international "think-in".

Schaaf M, Fox J, Topp SM, Warthin C, Freedman LP, Robinson RS, Thiagarajan S, Scott K, Maboe T, Zanchetta M, Ruano AL, Kok M, Closser S.

Int J Equity Health. 2018 May 25;17(1):66. doi: 10.1186/s12939-018-0781-5.

3.

What's in a sample? Increasing transparency in biospecimen procurement methods.

LaBaer J, Miceli JF 3rd, Freedman LP.

Nat Methods. 2018 Apr 27;15(5):303-304. doi: 10.1038/nmeth.4684. No abstract available.

PMID:
29702632
4.

Disrespectful and abusive treatment during facility delivery in Tanzania: a facility and community survey.

Kruk ME, Kujawski S, Mbaruku G, Ramsey K, Moyo W, Freedman LP.

Health Policy Plan. 2018 Jan 1;33(1):e26-e33. doi: 10.1093/heapol/czu079.

PMID:
29304252
5.

Methods used in prevalence studies of disrespect and abuse during facility based childbirth: lessons learned.

Sando D, Abuya T, Asefa A, Banks KP, Freedman LP, Kujawski S, Markovitz A, Ndwiga C, Ramsey K, Ratcliffe H, Ugwu EO, Warren CE, Jolivet RR.

Reprod Health. 2017 Oct 11;14(1):127. doi: 10.1186/s12978-017-0389-z. Review.

6.

Community and health system intervention to reduce disrespect and abuse during childbirth in Tanga Region, Tanzania: A comparative before-and-after study.

Kujawski SA, Freedman LP, Ramsey K, Mbaruku G, Mbuyita S, Moyo W, Kruk ME.

PLoS Med. 2017 Jul 11;14(7):e1002341. doi: 10.1371/journal.pmed.1002341. eCollection 2017 Jul.

7.

Reproducibility2020: Progress and priorities.

Freedman LP, Venugopalan G, Wisman R.

F1000Res. 2017 May 2;6:604. doi: 10.12688/f1000research.11334.1. eCollection 2017. Review.

8.

Matched preclinical designs for improved translatability.

Aittokallio T, Scherer A, Poutanen M, Freedman LP.

Sci Transl Med. 2017 May 10;9(389). pii: eaal4101. doi: 10.1126/scitranslmed.aal4101.

PMID:
28490671
9.

On rigor and replication.

Freedman LP.

Science. 2017 Apr 7;356(6333):34. doi: 10.1126/science.aam8039. Epub 2017 Apr 6. No abstract available.

PMID:
28385975
10.

Implementation and aspiration gaps: whose view counts?

Freedman LP.

Lancet. 2016 Oct 29;388(10056):2068-2069. doi: 10.1016/S0140-6736(16)31530-6. Epub 2016 Sep 16. No abstract available.

PMID:
27642027
11.

[Letter to the Editor] The need for improved education and training in research antibody usage and validation practices.

Freedman LP, Gibson MC, Bradbury AR, Buchberg AM, Davis D, Dolled-Filhart MP, Lund-Johansen F, Rimm DL.

Biotechniques. 2016 Jul 1;61(1):16-8. doi: 10.2144/000114431. eCollection 2016.

12.

The culture of cell culture practices and authentication--Results from a 2015 Survey.

Freedman LP, Gibson MC, Wisman R, Ethier SP, Soule HR, Reid YA, Neve RM.

Biotechniques. 2015 Oct 1;59(4):189-90, 192. doi: 10.2144/000114344. eCollection 2015 Oct. No abstract available.

13.

Does health insurance mitigate inequities in non-communicable disease treatment? Evidence from 48 low- and middle-income countries.

El-Sayed AM, Palma A, Freedman LP, Kruk ME.

Health Policy. 2015 Sep;119(9):1164-75. doi: 10.1016/j.healthpol.2015.07.006. Epub 2015 Jul 29.

14.

Moving Toward Patient-Centered Care in Africa: A Discrete Choice Experiment of Preferences for Delivery Care among 3,003 Tanzanian Women.

Larson E, Vail D, Mbaruku GM, Kimweri A, Freedman LP, Kruk ME.

PLoS One. 2015 Aug 11;10(8):e0135621. doi: 10.1371/journal.pone.0135621. eCollection 2015.

15.

Know Thy Cells: Improving Biomedical Research Reproducibility.

Freedman LP.

Sci Transl Med. 2015 Jul 1;7(294):294ed7. doi: 10.1126/scitranslmed.aac7112. No abstract available.

PMID:
26136474
16.

The Economics of Reproducibility in Preclinical Research.

Freedman LP, Cockburn IM, Simcoe TS.

PLoS Biol. 2015 Jun 9;13(6):e1002165. doi: 10.1371/journal.pbio.1002165. eCollection 2015 Jun. Erratum in: PLoS Biol. 2018 Apr 10;16(4):e1002626.

17.

Reproducibility: changing the policies and culture of cell line authentication.

Freedman LP, Gibson MC, Ethier SP, Soule HR, Neve RM, Reid YA.

Nat Methods. 2015 Jun;12(6):493-7. doi: 10.1038/nmeth.3403. No abstract available.

PMID:
26020501
18.

Association Between Disrespect and Abuse During Childbirth and Women's Confidence in Health Facilities in Tanzania.

Kujawski S, Mbaruku G, Freedman LP, Ramsey K, Moyo W, Kruk ME.

Matern Child Health J. 2015 Oct;19(10):2243-50. doi: 10.1007/s10995-015-1743-9.

PMID:
25990843
19.

Antibodies: Validate recombinants too.

Freedman LP.

Nature. 2015 Feb 26;518(7540):483. doi: 10.1038/518483c. No abstract available.

PMID:
25719653
20.

The impact of preclinical irreproducibility on drug development.

Freedman LP, Gibson MC.

Clin Pharmacol Ther. 2015 Jan;97(1):16-8. doi: 10.1002/cpt.9. Epub 2014 Dec 2.

PMID:
25670378
21.

Defining disrespect and abuse of women in childbirth: a research, policy and rights agenda.

Freedman LP, Ramsey K, Abuya T, Bellows B, Ndwiga C, Warren CE, Kujawski S, Moyo W, Kruk ME, Mbaruku G.

Bull World Health Organ. 2014 Dec 1;92(12):915-7. doi: 10.2471/BLT.14.137869. Epub 2014 Oct 6. No abstract available.

22.

The increasing urgency for standards in basic biologic research.

Freedman LP, Inglese J.

Cancer Res. 2014 Aug 1;74(15):4024-9. doi: 10.1158/0008-5472.CAN-14-0925. Epub 2014 Jul 17.

23.

Disrespect and abuse of women in childbirth: challenging the global quality and accountability agendas.

Freedman LP, Kruk ME.

Lancet. 2014 Sep 20;384(9948):e42-4. doi: 10.1016/S0140-6736(14)60859-X. Epub 2014 Jun 22. No abstract available.

PMID:
24965825
24.

Unmasking the open secret of posting and transfer practices in the health sector.

Schaaf M, Freedman LP.

Health Policy Plan. 2015 Feb;30(1):121-30. doi: 10.1093/heapol/czt091. Epub 2013 Dec 9. Review.

25.

Act global, but think local: accountability at the frontlines.

Freedman LP, Schaaf M.

Reprod Health Matters. 2013 Nov;21(42):103-12. doi: 10.1016/S0968-8080(13)42744-1.

26.

Preventing maternal and newborn deaths globally: using innovation and science to address challenges in implementing life-saving interventions.

Peterson HB, Haidar J, Merialdi M, Say L, Gülmezoglu AM, Fajans PJ, Mbizvo MT, Ghaffar A, Tran NT, de Bernis L, Laski L, Freedman LP, Chopra M.

Obstet Gynecol. 2012 Sep;120(3):636-42.

PMID:
22914474
27.

Equity of inpatient health care in rural Tanzania: a population- and facility-based survey.

Ferry GA, Dickson SR, Mbaruku G, Freedman LP, Kruk ME.

Int J Equity Health. 2012 Feb 15;11:7. doi: 10.1186/1475-9276-11-7.

28.

Integrating HIV and maternal health services: will organizational culture clash sow the seeds of a new and improved implementation practice?

Freedman LP.

J Acquir Immune Defic Syndr. 2011 Aug;57 Suppl 2:S80-2. doi: 10.1097/QAI.0b013e31821dba2d.

PMID:
21857302
29.

Liver X receptor-retinoid X receptor (LXR-RXR) heterodimer cistrome reveals coordination of LXR and AP1 signaling in keratinocytes.

Shen Q, Bai Y, Chang KC, Wang Y, Burris TP, Freedman LP, Thompson CC, Nagpal S.

J Biol Chem. 2011 Apr 22;286(16):14554-63. doi: 10.1074/jbc.M110.165704. Epub 2011 Feb 24.

30.

Identification of 5α, 6α-epoxycholesterol as a novel modulator of liver X receptor activity.

Berrodin TJ, Shen Q, Quinet EM, Yudt MR, Freedman LP, Nagpal S.

Mol Pharmacol. 2010 Dec;78(6):1046-58. doi: 10.1124/mol.110.065193. Epub 2010 Sep 13.

PMID:
20837678
31.

Discovery of the selective androgen receptor modulator MK-0773 using a rational development strategy based on differential transcriptional requirements for androgenic anabolism versus reproductive physiology.

Schmidt A, Kimmel DB, Bai C, Scafonas A, Rutledge S, Vogel RL, McElwee-Witmer S, Chen F, Nantermet PV, Kasparcova V, Leu CT, Zhang HZ, Duggan ME, Gentile MA, Hodor P, Pennypacker B, Masarachia P, Opas EE, Adamski SA, Cusick TE, Wang J, Mitchell HJ, Kim Y, Prueksaritanont T, Perkins JJ, Meissner RS, Hartman GD, Freedman LP, Harada S, Ray WJ.

J Biol Chem. 2010 May 28;285(22):17054-64. doi: 10.1074/jbc.M109.099002. Epub 2010 Mar 31.

32.

Estrogen receptor beta is a novel therapeutic target for photoaging.

Chang KC, Wang Y, Oh IG, Jenkins S, Freedman LP, Thompson CC, Chung JH, Nagpal S.

Mol Pharmacol. 2010 May;77(5):744-50. doi: 10.1124/mol.109.062877. Epub 2010 Jan 28.

PMID:
20110405
33.

Rebuilding health systems to improve health and promote statebuilding in post-conflict countries: a theoretical framework and research agenda.

Kruk ME, Freedman LP, Anglin GA, Waldman RJ.

Soc Sci Med. 2010 Jan;70(1):89-97. doi: 10.1016/j.socscimed.2009.09.042. Epub 2009 Oct 21.

PMID:
19850390
34.

Androgen-mediated improvement of body composition and muscle function involves a novel early transcriptional program including IGF1, mechano growth factor, and induction of {beta}-catenin.

Gentile MA, Nantermet PV, Vogel RL, Phillips R, Holder D, Hodor P, Cheng C, Dai H, Freedman LP, Ray WJ.

J Mol Endocrinol. 2010 Jan;44(1):55-73. doi: 10.1677/JME-09-0048. Epub 2009 Sep 2.

PMID:
19726620
35.

Differential biochemical and cellular actions of Premarin estrogens: distinct pharmacology of bazedoxifene-conjugated estrogens combination.

Berrodin TJ, Chang KC, Komm BS, Freedman LP, Nagpal S.

Mol Endocrinol. 2009 Jan;23(1):74-85. doi: 10.1210/me.2008-0366. Epub 2008 Nov 26.

36.

The skinny on fat: how oxysterols may regulate functional glucocorticoids in adipose tissue.

Yudt MR, Freedman LP.

Endocrinology. 2008 Dec;149(12):5907-8. doi: 10.1210/en.2008-1340. No abstract available.

PMID:
19022897
37.

Liver X receptor is a therapeutic target for photoaging and chronological skin aging.

Chang KC, Shen Q, Oh IG, Jelinsky SA, Jenkins SF, Wang W, Wang Y, LaCava M, Yudt MR, Thompson CC, Freedman LP, Chung JH, Nagpal S.

Mol Endocrinol. 2008 Nov;22(11):2407-19. doi: 10.1210/me.2008-0232. Epub 2008 Sep 11.

PMID:
18787039
38.

MNAR plays an important role in ERa activation of Src/MAPK and PI3K/Akt signaling pathways.

Cheskis BJ, Greger J, Cooch N, McNally C, Mclarney S, Lam HS, Rutledge S, Mekonnen B, Hauze D, Nagpal S, Freedman LP.

Steroids. 2008 Oct;73(9-10):901-5. doi: 10.1016/j.steroids.2007.12.028. Epub 2008 Jan 4. Review.

PMID:
18261753
39.

Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survival.

Krum SA, Miranda-Carboni GA, Hauschka PV, Carroll JS, Lane TF, Freedman LP, Brown M.

EMBO J. 2008 Feb 6;27(3):535-45. doi: 10.1038/sj.emboj.7601984. Epub 2008 Jan 24.

40.

Health system strengthening: new potential for public health and human rights collaboration.

Freedman LP.

Reprod Health Matters. 2007 Nov;15(30):219-20. No abstract available.

41.

Practical lessons from global safe motherhood initiatives: time for a new focus on implementation.

Freedman LP, Graham WJ, Brazier E, Smith JM, Ensor T, Fauveau V, Themmen E, Currie S, Agarwal K.

Lancet. 2007 Oct 13;370(9595):1383-91. Review.

PMID:
17933654
42.

Assessing health system performance in developing countries: a review of the literature.

Kruk ME, Freedman LP.

Health Policy. 2008 Mar;85(3):263-76. Epub 2007 Oct 10. Review.

PMID:
17931736
43.

Selective androgen receptor modulators for frailty and osteoporosis.

Kilbourne EJ, Moore WJ, Freedman LP, Nagpal S.

Curr Opin Investig Drugs. 2007 Oct;8(10):821-9. Review.

PMID:
17907058
44.

Signaling by estrogens.

Cheskis BJ, Greger JG, Nagpal S, Freedman LP.

J Cell Physiol. 2007 Dec;213(3):610-7. Review.

PMID:
17886255
45.

A regulatory circuit mediating convergence between Nurr1 transcriptional regulation and Wnt signaling.

Kitagawa H, Ray WJ, Glantschnig H, Nantermet PV, Yu Y, Leu CT, Harada S, Kato S, Freedman LP.

Mol Cell Biol. 2007 Nov;27(21):7486-96. Epub 2007 Aug 20. Retraction in: Mol Cell Biol. 2014 Mar;34(5):917.

46.

Health care financing and utilization of maternal health services in developing countries.

Kruk ME, Galea S, Prescott M, Freedman LP.

Health Policy Plan. 2007 Sep;22(5):303-10. Epub 2007 Aug 5.

PMID:
17681975
47.

Making motherhood safe in developing countries.

Rosenfield A, Min CJ, Freedman LP.

N Engl J Med. 2007 Apr 5;356(14):1395-7. No abstract available.

48.

Phosphorylation of MNAR promotes estrogen activation of phosphatidylinositol 3-kinase.

Greger JG, Fursov N, Cooch N, McLarney S, Freedman LP, Edwards DP, Cheskis BJ.

Mol Cell Biol. 2007 Mar;27(5):1904-13. Epub 2006 Dec 28. Retraction in: Mol Cell Biol. 2010 Mar;30(6):1568.

49.

Vitamin D receptor ligands for osteoporosis.

Cheskis BJ, Freedman LP, Nagpal S.

Curr Opin Investig Drugs. 2006 Oct;7(10):906-11. Review.

PMID:
17086935
50.

Nuclear receptors as drug targets in metabolic diseases: new approaches to therapy.

Tobin JF, Freedman LP.

Trends Endocrinol Metab. 2006 Sep;17(7):284-90. Epub 2006 Jul 25. Review.

PMID:
16870465

Supplemental Content

Loading ...
Support Center